Stephen L. Holcombe
2016
In 2016, Stephen L. Holcombe earned a total compensation of $682.1K as President and Chief Executive Officer at vTv Therapeutics, a 74% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Salary | $450,000 |
| Other | $7,146 |
| Total | $682,146 |
Holcombe received $450K in salary, accounting for 66% of the total pay in 2016.
Holcombe also received $225K in non-equity incentive plan and $7.1K in other compensation.
Rankings
In 2016, Stephen L. Holcombe's compensation ranked 9,998th out of 14,075 executives tracked by ExecPay. In other words, Holcombe earned more than 29.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,998 out of 14,075 | 29th |
Division Manufacturing | 3,856 out of 5,486 | 30th |
Major group Chemicals And Allied Products | 1,355 out of 1,900 | 29th |
Industry group Drugs | 1,082 out of 1,543 | 30th |
Industry Pharmaceutical Preparations | 848 out of 1,173 | 28th |
Source: SEC filing on March 16, 2018.
Holcombe's colleagues
We found two more compensation records of executives who worked with Stephen L. Holcombe at vTv Therapeutics in 2016.
News
vTv Therapeutics CEO Deepa Prasad receives $3.3M in 2021
May 2, 2022
vTv Therapeutics CEO Stephen Holcombe's 2020 pay jumps 68% to $1.4M
March 18, 2021
vTv Therapeutics CEO Stephen Holcombe's 2019 pay jumps 81% to $833K
April 30, 2020
vTv Therapeutics CEO Stephen Holcombe's 2018 pay falls 63% to $459K
March 15, 2019